Company attributes
Location
B2X
CEO
Pitchbook URL
Legal Name
Adicet Bio, Inc.
Date Incorporated
2014
Number of Employees (Ranges)
51 – 200
Phone Number
+165050390950
Full Address
200 Clarendon St, Floor 6 Suite #6041 Boston, MA 021160
200 Constitution Drive Menlo Park, CA 94025
1000 Bridge Parkway Redwood City, CA 940650
CIK Number
Place of Incorporation
Investors
DUNS Number
0796098050
IRS Number
813,305,2770
Founded Date
2014
Total Funding Amount (USD)
160,000,000
Latest Funding Round Date
October 2, 2019
Competitors
Stock Symbol
ACET0
Exchange
Glassdoor ID
Board of Directors
CTO
CFO
Latest Funding Type
CAGE Code
7VHT70
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
80,000,000
Previous Name
resTORbio, Inc.0
SIC Code
2,8340
Ticker Symbol
ACET
Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases that is headquartered in Menlo park, California and was founded in 2014 by Aya Jakobovitis.
Funding
Venture
On August 26, 2015 Adicet Bio completed a venture capital round raising $14.6 million in funding from undisclosed investors.
Series A
On January 27, 2016 Adicet Bio completed their series A funding round with $51 million in funding from OrbiMed (lead investor), Pontifax, and Novartis Venture Fund.
Acquisitions
Applied Immune Technologies
On January 27, 2016 Adicet Bio acquired the Israeli immunotherapy company Applied Immune Technologies.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
